1. Home
  2. AMSC vs NVAX Comparison

AMSC vs NVAX Comparison

Compare AMSC & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Superconductor Corporation

AMSC

American Superconductor Corporation

HOLD

Current Price

$33.14

Market Cap

1.7B

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.20

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMSC
NVAX
Founded
1987
1987
Country
United States
United States
Employees
400
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2012
1996

Fundamental Metrics

Financial Performance
Metric
AMSC
NVAX
Price
$33.14
$8.20
Analyst Decision
Strong Buy
Hold
Analyst Count
1
9
Target Price
$52.00
$11.33
AVG Volume (30 Days)
824.0K
4.2M
Earning Date
05-20-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
1806.25
309.76
EPS
3.05
N/A
Revenue
$900,000.00
$1,123,479,000.00
Revenue This Year
$34.98
N/A
Revenue Next Year
$21.38
N/A
P/E Ratio
$10.78
N/A
Revenue Growth
N/A
64.69
52 Week Low
$24.87
$6.20
52 Week High
$70.49
$11.85

Technical Indicators

Market Signals
Indicator
AMSC
NVAX
Relative Strength Index (RSI) 34.52 35.70
Support Level $29.35 $7.78
Resistance Level $33.57 $10.10
Average True Range (ATR) 2.18 0.43
MACD -0.23 -0.12
Stochastic Oscillator 16.86 6.80

Price Performance

Historical Comparison
AMSC
NVAX

About AMSC American Superconductor Corporation

American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: